Molecular Characterization of the Predominant Influenza A(H1N1)pdm09 Virus in Mexico, December 2011-February 2012

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  de la Rosa Zamboni, Daniela ^a   Vázquez Pérez, Joel A ^a   Ávila Ríos, Santiago ^a   Carranco Arenas, Ana Paola ^a   Ormsby, Christopher E ^a   Cummings, Craig A ^b,c   Soto Nava, Maribel ^a   Hernández Hernández, Víctor A ^a   Orozco Sánchez, Carmen O ^a   la Barrera, Claudia Alvarado de ^a   Pérez Padilla, Rogelio ^a   Reyes Terán, Gustavo ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b Life Technologies Corporation   (United States)

^c Sequenta Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR;

ADULT; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HUMAN; IMMUNE EVASION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; MEXICO; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; PHYLOGENY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL VARIATION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS ISOLATION;

GENOME, VIRAL; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; INTERNATIONAL COOPERATION; MEXICO; PHYLOGENY; POLYMORPHISM, GENETIC; PROTEIN CONFORMATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEQUENCE ANALYSIS, DNA;

CERCOPITHECINE HERPESVIRUS 1; ORTHOMYXOVIRIDAE;

EID: 84870557921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050116     Document Type: Article

References (36)

1. Update: swine influenza A (H1N1) infections-California and Texas, April 2009 (2009) MMWR Morb Mortal Wkly Rep 58: 435-437.
2. WHO {pipe} Pandemic influenza A(H1N1)- draft donor report (n.d.). WHO. Available: http://www.who.int/csr/resources/publications/swineflu/h1n1_donor_032011/en/index.html. Accessed 2012 Jun 16.
3. WHO {pipe} FluNet- CHARTS (n.d.). Available: http://www.who.int/influenza/gisrs_laboratory/flunet/charts/en/index.html. Accessed 2012 Mar 13.
4. Chowell G, Echevarría-Zuno S, Viboud C, Simonsen L, Grajales Muñiz C, et al. (2012) Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: Age shift and severity. PLoS currents 4: RRN1306 doi:10.1371/currents.RRN1306.
5. Beaute J, Broberg E, Plata F, Bonmarin I, O Donnell J, et al. (2012) Overrepresentation of influenza A(H1N1)pdm09 virus among severe influenza cases in the 2011/12 season in four European countries. Euro Surveill 17Available: http://www.ncbi.nlm.nih.gov/pubmed/22401564. Accessed 2012 Mar 13.
6. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, et al. (2009) Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol 83: 10309-10313 doi:10.1128/JVI.01109-09.
7. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079 doi:10.1093/bioinformatics/btp352.
8. Squires RB, Noronha J, Hunt V, García-Sastre A, Macken C, et al. (2012) Influenza Research Database: an integrated bioinformatics resource for influenza research and surveillance. Influenza and Other Respiratory Viruses Available: http://www.ncbi.nlm.nih.gov/pubmed/22260278. Accessed 2012 Mar 14.
9. Katoh K, Misawa K, Kuma K, Miyata T, (2002) MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 30: 3059-3066.
10. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739 doi:10.1093/molbev/msr121.
11. Paradis E, Claude J, Strimmer K, (2004) APE: Analyses of Phylogenetics and Evolution in R language. Bioinformatics 20: 289-290.
12. Kimura M, (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16: 111-120.
13. WHO {pipe} Influenza transmission zones (n.d.). WHO. Available: http://www.who.int/csr/disease/swineflu/transmission_zones/en/. Accessed 2012 Jun 28.
14. Lambert C, Léonard N, De Bolle X, Depiereux E, (2002) ESyPred3D: Prediction of proteins 3D structures. Bioinformatics 18: 1250-1256.
15. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr, et al. (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328: 357-360 doi:10.1126/science.1186430.
16. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25 (13) (): 1605-12.
17. Wu J, Xu F, Lu L, Lu M, Miao L, et al. (2010) Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med 363: 2416-2423 doi:10.1056/NEJMoa1006736.
18. Trejo-Valdivia B, Mendoza-Alvarado LR, Palma-Coca O, Hernández-Ávila M, Téllez-Rojo Solís MM, (2012) [National Survey of Vaccination Coverage (Influenza, pneumococcus and tetanus) in Mexican population of 60 years of age and older]. Salud Publica Mex 54: 39-46.
19. Maurer-Stroh S, Lee RTC, Eisenhaber F, Cui L, Phuah SP, et al. (2010) A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza A virus. PLoS Curr 2: RRN1162.
20. Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H, et al. (2010) Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS ONE 5: e8553 doi:10.1371/journal.pone.0008553.
21. Munster VJ, de Wit E, van Riel D, Beyer WEP, Rimmelzwaan GF, et al. (2007) The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis 196: 258-265 doi:10.1086/518792.
22. Hatta M, Hatta Y, Kim JH, Watanabe S, Shinya K, et al. (2007) Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog 3: 1374-1379 doi:10.1371/journal.ppat.0030133.
23. Liu Y, Childs RA, Matrosovich T, Wharton S, Palma AS, et al. (2010) Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J Virol 84: 12069-12074 doi:10.1128/JVI.01639-10.
24. Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA, (2008) A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci USA 105: 4381-4386 doi:10.1073/pnas.0800482105.
25. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P, (2007) A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3: 1414-1421 doi:10.1371/journal.ppat.0030141.
26. Ellis J, Galiano M, Pebody R, Lackenby A, Thompson C, et al. (2011) Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill 16Available: http://www.ncbi.nlm.nih.gov/pubmed/21223836. Accessed 2012 Jun 16.
27. Mak GC, Leung CK, Cheng KC, Wong KY, Lim W, (2011) Evolution of the haemagglutinin gene of the influenza A(H1N1)2009 virus isolated in Hong Kong, 2009-2011. Euro Surveill 16Available: http://www.ncbi.nlm.nih.gov/pubmed/21392488. Accessed 2012 Jun 16.
28. Barr IG, Cui L, Komadina N, Lee RT, Lin RT, et al. (2010) A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Euro Surveill 15Available: http://www.ncbi.nlm.nih.gov/pubmed/21034722. Accessed 2012 Jun 16.
29. Inoue E, Ieko M, Takahashi N, Osawa Y, Okazaki K, (2012) Phylogenetic analyses of pandemic influenza A (H1N1) virus in university students at Tobetsu, Hokkaido, Japan. Microbiol Immunol 56: 273-279 doi:10.1111/j.1348-0421.2012.00432.x.
30. Mir MA, Lal RB, Sullender W, Singh Y, Garten R, et al. (2012) Genetic diversity of HA1 domain of hemagglutinin gene of pandemic influenza H1N1pdm09 viruses in New Delhi, India. J Med Virol 84: 386-393 doi:10.1002/jmv.23205.
31. Solomina AA, Grudinin MP, Eropkin MI, Karpova LS, Pisareva MM, et al. (2011) [Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center]. Zh Mikrobiol Epidemiol Immunobiol pp. 20-26.
32. Galiano M, Agapow P-M, Thompson C, Platt S, Underwood A, et al. (2011) Evolutionary pathways of the pandemic influenza A (H1N1) 2009 in the UK. PLoS ONE 6: e23779 doi:10.1371/journal.pone.0023779.
33. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, et al. (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361: 680-689 doi:10.1056/NEJMoa0904252.
34. Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, et al. (2010) Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS ONE 5: e9694 doi:10.1371/journal.pone.0009694.
35. WHO {pipe} Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season (n.d.). WHO. Available: http://www.who.int/influenza/vaccines/virus/recommendations/2012_13_north/en/index.html. Accessed 2012 Jun 16.
36. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, et al. (2005) Avian flu: isolation of drug-resistant H5N1 virus. Nature 437: 1108 doi:10.1038/4371108a.